Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:morphine_sulfate
|
| gptkbp:ATCCode |
N02AA01
|
| gptkbp:brand |
gptkb:morphine
|
| gptkbp:controlledSubstanceSchedule |
yes
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sevredol
|
| gptkbp:legalStatus |
controlled drug (varies by country)
|
| gptkbp:manufacturer |
gptkb:Mundipharma
|
| gptkbp:mechanismOfAction |
opioid receptor agonist
|
| gptkbp:overdoseSymptoms |
high
|
| gptkbp:pregnancyCategory |
varies by country
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskOfDependence |
yes
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation drowsiness |
| gptkbp:usedFor |
pain management
|
| gptkbp:bfsParent |
gptkb:Morphine
|
| gptkbp:bfsLayer |
6
|